SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-24-038779
Filing Date
2024-05-02
Accepted
2024-05-02 09:18:39
Documents
108
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 20-F ea0205098-20fa1_scisparc.htm   iXBRL 20-F/A 1291639
2 CERTIFICATION ea020509801ex12-1_scisparc.htm EX-12.1 4577
3 CERTIFICATION ea020509801ex13-1_scisparc.htm EX-13.1 3936
4 CONSENT OF KOST FORER GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL, INDEP ea020509801ex15-1_scisparc.htm EX-15.1 3220
5 GRAPHIC image_001.jpg GRAPHIC 1811
  Complete submission text file 0001213900-24-038779.txt   7533133

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sprcy-20231231.xsd EX-101.SCH 135768
7 XBRL CALCULATION FILE sprcy-20231231_cal.xml EX-101.CAL 44595
8 XBRL DEFINITION FILE sprcy-20231231_def.xml EX-101.DEF 344869
9 XBRL LABEL FILE sprcy-20231231_lab.xml EX-101.LAB 777326
10 XBRL PRESENTATION FILE sprcy-20231231_pre.xml EX-101.PRE 368204
112 EXTRACTED XBRL INSTANCE DOCUMENT ea0205098-20fa1_scisparc_htm.xml XML 1226123
Mailing Address 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV L3 6971916
Business Address 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV L3 6971916 972-3-6103100
SciSparc Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-38041 | Film No.: 24905681
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)